Xcout Intel
Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development of therapies using Tumor Treating Fields.
Subscribe to see Novocure’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Novocure at a glance
Novocure is a biotechnology company headquartered in Jersey. It is publicly listed (NVCR) with a market capitalisation of $1.8B. Xcout tracks 18 named people at Novocure, including Frank Leonard (Chief Executive Officer & Director). Xcout recorded 2 job postings from Novocure in the last 90 days.
Novocure leadership
- Frank LeonardChief Executive Officer & Director
- Mukund ParavasthuChief Operating Officer
- Christoph BrackmannChief Financial Officer
- Uri WeinbergChief Innovation Officer & Chief Medical Officer
- Michael PuriChief Human Resources Officer
- William F. DoyleExecutive Chairman
12 more named people on record for Novocure, with roles, board committees and tenure — see the full roster →
Hiring at Novocure
Xcout recorded 2 job postings from Novocure in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Novocure's hiring signals →
Investors
Novocure competitors
A few of Novocure's closest competitors — see the full list of competitors and alternatives →
Haniva Technology LLC is a biotechnology company that develops patented combination therapies and drug delivery devices to treat various forms of cancer. Its research focuses on using non-thermal plasma alongside hypoxia-activated DNA-damaging agents to selectively target and reduce tumor volume, prevent metastasis, and serve as an adjuvant treatment following tumor resection.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Kortuc Inc. develops cancer radiotherapy solutions, specifically offering an innovative radiosensitizer designed to eliminate tumor hypoxia and maximize the effectiveness of radiation treatment. The company serves the medical and oncology research sectors by advancing clinical trials and expanding treatment options for cancer patients.
KAIO Therapy, LLC develops an Immune Activating Heat Therapy (IAHT) technology designed to treat cancer patients by combining hyperthermia with immunotherapy. The system utilizes injected nanoparticles and an alternating magnetic field device to induce controlled heat within tumors, which destroys cancer cells and activates the patient's immune system against primary and metastatic tumors.
Oleander Medical Technologies is developing a cancer treatment called Targeted Osmotic Lysis (TOL), which destroys malignant cells by forcing them to absorb excessive sodium and burst. The therapy combines an existing heart medication with an investigational pulsed electric field device to target cancers with elevated sodium channel expression while leaving healthy cells unharmed.
Kuros Biosciences AG is a Swiss-headquartered biotech company, listed on the SIX Swiss Exchange. The company focuses on growing bone with products like MagnetOs Bone Graft.
Get Novocure's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Novocure in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access